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Abstract
Objective: The aim of this study was to assess outcomes related to general quality of life,
daytime sleepiness and functional sleep outcomes, functional outcomes of orthognathic
surgery, and facial aesthetics in patients undergoing maxillomandibular advancement
(MMA) surgery for the treatment of obstructive sleep apnea (OSA).
Materials and Methods: This was a cross-sectional self-report study. A questionnaire was
constructed using questions drawn from previously validated questionnaires. The survey was
distributed to 25 patients who underwent MMA surgery for the treatment of OSA at LHSC in
London, Ontario by a single surgeon between 2002 and 2013.
Results: The survey results showed that MMA patients responded positively with respect to
quality of life, snoring, functional sleep outcomes and daytime sleepiness, and facial
aesthetics. Nineteen (86.4%) indicated that their sleep apnea symptoms have improved since
the surgery. Eighteen (81.8%) reported neutral or positive changes with respect to facial
attractiveness. Nineteen (86.4%) indicated that their overall quality of life has become better
since having MMA. Most patients indicated that the surgery was worthwhile and would
recommend it to others suffering from OSA.
Conclusions: MMA surgery for the treatment of OSA appears to have an overall positive
effect on quality of life, sleep outcomes, and aesthetic outcomes. The majority of patients
found the surgery worthwhile. Orthodontic treatment in conjunction with MMA appears to
enhance the subjective aesthetic outcomes of treatment.
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Review of the Literature

Epidemiology
Obstructive sleep apnea (OSA) is a sleep disorder in which complete or partial
airway obstruction causes disruptive sleep and excessive daytime sleepiness. The result
of airway obstruction may be characterized as hypopneas, where airflow into the lungs is
reduced and blood oxygen saturation decreases, or apneas, where airway patency is
completely absent for a period of time and breathing stops. The primary measure of the
severity of a patient’s OSA is the apnea-hypopnea index, or AHI, which is defined as the
total number of apneic plus hypopneic episodes, divided by the time slept in hours. For a
diagnosis of OSA, 5 or more episodes of apnea and/or hypopnea per hour must be
observed in a controlled sleep study (AHI=5).1 In addition to the AHI, the respiratory
disturbance index (RDI) is sometimes used. The RDI takes into account the number of
apneas and hypopneas, but also includes RERAs, or respiratory effort-related arousals,
which are defined as increases in respiratory activity leading to arousal from sleep that do
not qualify as apneas or hypopneas.2
The term obstructive sleep apnea syndrome (OSAS) may be applied when
increased AHI is accompanied by excessive daytime sleepiness.3 The Epworth sleepiness
scale (ESS), a simple questionnaire, is currently the most commonly used measure to
assess daytime sleepiness.4 The gold standard test for daytime sleepiness is the multiple
sleep latency test (MSLT), which is a laboratory-administered full-day test that is meant
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to objectively assess daytime sleepiness.5 Due to the high cost and low convenience to
patients, the ESS is typically used instead.
OSA is a common, but often unrecognized disorder with a prevalence of 2% in
middle aged women, and 4% in middle-aged men.6 It has been proposed that due to the
increasing average body mass index (BMI), this prevalence could be increasing. It has
been estimated that up to 82% of men and 93% of women with OSA have not been
clinically diagnosed.7 Individuals with OSA have disrupted sleep patterns due to reduced
activity of the muscles of the pharyngeal wall, decreased oxygen saturation, and
increased arousal, which leads to insufficient rapid eye movement (REM) sleep.8 This
irregular sleep pattern manifests as daytime sleepiness and fatigue, which have been
shown to have a number of negative sequelae, including hypersomnolence, cognitive
dysfunction, impaired work performance, increased risk of cardiovascular disease, type II
diabetes, and metabolic syndrome.9 Individuals with OSA are at increase risk of
accidents, particularly when driving,10 indicating the urgent need to detect and diagnose
OSA patients.
Obesity is a major comorbidity associated with OSA, as well as a predisposing
factor. A 10% weight gain increases the risk of OSA by six times.11 This is particularly a
problem in North America, where approximately one third of the adult population is
obese.11 In addition to contributing to the pathophysiology of the disease, excess body fat
also acts as a contributing factor to various comorbidities of OSA, including diabetes
mellitus12, metabolic syndrome,13 and cardiovascular disease.14 Several studies have
demonstrated that weight reduction by caloric restriction and exercise reduced the
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symptoms of OSA in the majority of cases, and these observations were consistent at
long term follow up.15 Therefore, weight loss may be considered as a low-cost, first line
treatment for OSA, ideally before more invasive treatments are rendered.

Pathophysiology
The pathophysiology behind OSA involves several potential sites of airway
obstruction in the head and neck region, involving both anatomic structures and
neuromuscular forces. The human pharynx can be thought of a tube with no rigid skeletal
support. When the extraluminal pressures from the surrounding soft tissues exceed the
forces provided by the muscles of the pharyngeal wall, apneas and/or hypopneas are
prone to occur.1 During wakefulness, increased muscle tone generally compensates for
the narrowed airway, but these reflexes are less active during sleep.16
The retropalatal (posterior to the soft palate) and retroglossal (posterior to the
tongue base) areas are the most important potential sites of obstruction. It is essential to
diagnose each patient on an individual basis, as one or both of these sites may be
obstructed, and the prescribed treatment may depend on which sites are affected.17
Excessive body fat can cause excessive narrowing in these regions, but other anatomical
features are associated with OSA, including retrognathia, micrognathia, long face
syndrome, increased cranial base flexion, and elongation of the soft palate.17,18 Other
features, such as reduced midface length, a retrusive upper lip, inferior hyoid bone, and
reduced pharyngeal airway patency are commonly observed on cephalograms, and these
features are also associated with smaller airway dimensions.19 Lateral cephalograms may
be taken quickly and at low cost, and are available in most orthodontic clinics, making
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them useful adjuncts for OSA diagnosis and treatment. However, due to a number of
shortcomings associated with 2-dimensional cephalometry, 3-dimensional dynamic
imaging modalities would be more useful in assessing airway function.
Reductions in airway volume lead to a number of clinical features typical of
patients with OSA. These include snoring, snorting, gasping, and choking during periods
of sleep, as well as intermittent awakenings, insomnia, and headaches. Patients are more
likely to complain about symptoms present during periods of wakefulness, which include
sleepiness, fatigue, and hypersomnolence. Indeed, many patients are unaware of their
nocturnal symptoms, which makes detection and diagnosis of these patients difficult.1

Treatment Options
Various treatment modalities exist for patients with OSA, which may or may not
involve surgical procedures. Before any treatment can be recommended, it is imperative
that the patient be properly diagnosed in concordance with a physician via a
polysomnographic sleep study.2 This is so that the severity and etiology of the patient’s
OSA can be determined. As mentioned previously, many OSA patients are overweight or
obese, and weight reduction protocol should be considered a first line treatment for OSA.
A BMI of 28 or higher has shown to increase the likelihood of developing moderate to
severe OSA 5-fold.20
Several non-surgical interventions exist. The current gold standard is continuous
positive airway pressure (CPAP). A machine is used to increase pressure within the
pharynx, thus maintaining airway patency during inhalation and exhalation. Studies have
shown that CPAP treatment can be greatly successful in reducing snoring, daytime
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sleepiness, and other OSA symptoms, especially in patients with severe OSA.21 The
positive effects on patients with milder forms of OSA are not as dramatic.22 Indirect
effects from the use of CPAP include reduced susceptibility to cardiovascular disease,
increased alertness, reduced motor vehicle accidents, and reduction in nocturnal GERD.2
One of the largest barriers to successful CPAP treatment is patient compliance.
Compliance from nasal CPAP has been reported as ranging from 50% to 89%.23 Lack of
compliance often arises as patients find the treatment intolerable for one reason or
another. Common complaints from patients who use CPAP include nasal congestion,
dryness of the oral and pharyngeal tissues, skin rash from the mask, irritation, and pain.
Less commonly, anxiety, claustrophobia, gastric distension, and ear/sinus infections have
been reported.1
Oral appliances that reposition the mandible anteriorly, along with the tongue and
hyoid bone, may be considered in patients with mild to moderate OSA as an alternative to
CPAP. In advancing the mandible and its associated structures during sleep, the
retroglossal airway patency is increased. Typically, the mandible is temporarily advanced
up to 80% of its maximum protrusive capability while the appliance is worn. Before and
after polysomnographic sleep studies are recommended to gauge the effectiveness of the
treatment. Currently, oral appliances are not quite as effective as CPAP in reducing AHI
scores below 5 and improving other symptoms.24 This may be due to oral appliances
addressing only the retroglossal site of obstruction. However, there are several
advantages to using these appliances over CPAP, including low cost, less noise, less bulk,
and greater acceptance by patients and their partners.2 Due to the active nature of these
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appliance, tooth movement and TMJ pain are common complaints,25 so each patient
should be monitored regularly by an appropriately trained dental professional.
Historically, the terms stage I and stage II surgery have been used to categorize
the surgical techniques to treat OSA, with stage I being soft tissue resective surgery and
stage II being hard tissue surgery (for example, maxillomandibular advancement or
MMA). In the past, stage I surgery was considered first-line treatment, with MMA being
considered only after soft tissue surgery had first failed to adequately reduce OSA
symptoms. However, modern orthognathic techniques are able to produce predictable
results with low morbidity, and there are several marked negative sequelae associate with
soft tissue resection. Thus, MMA is increasingly being considered as a first-line surgical
treatment for OSA.
Stage I, or soft tissue surgery aims to increase upper airway patency by removal
of soft tissues in the oral, nasal, and pharyngeal cavities. While it is often insufficient to
perform in isolation, nasal surgery may be considered as an adjunct to other surgeries.26
Partial glossectomy may be considered only if it is determined that macroglossia is a
contributing factor to a patient’s OSA. This surgery is rarely indicated, as the associated
morbidities, including dysphagia, odynophagia, loss of taste, and reduced mobility of the
tongue, are difficult for patients to tolerate.2
While tracheostomy was the first surgery developed for treatment of OSAS (and
perhaps the most effective), it is poorly tolerated by patients and is rarely offered as a
long term treatment for OSA.27 A major development was the
uvulopalatopharyngoplasty, or UPPP, modified by Fujita et al28 to treat OSA. In this
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procedure, the uvula posterior soft palate, and pharyngeal tonsils are resected in one
surgery in order to increase the retropalatal airway. Unfortunately, reduction in AHI
observed in most studies is modest at best (about 50% success), and the technique is best
used in conjunction with other surgical procedures.29 The limited success is due in part to
the fact that the procedure addresses one area of obstruction only. Velopharyngeal
insufficiency is sometimes present after UPPP, which may cause hypernasal speech,
speech difficulties, and nasal reflux. Nasal airway obstruction secondary to scar tissue
formation from the surgery may also develop.2 UPPP is very effective in reducing
snoring, however, and may be considered as a primary therapy for patients whose main
complaint is snoring in the absence of other OSA symptoms.30 Therefore, patient
selection for this procedure is of critical importance, and must be limited to those who
possess enough excessive retropalatal soft tissue to resect without causing velopharyngeal
insufficiency.
Maxillomandibular advancement is more effective than UPPP surgery, and is
accepted as the most successful surgical technique for the treatment of OSAS.31
Traditionally, a phased approach to surgical treatment has been followed, with more socalled conservative surgeries like UPPP being performed first, while MMA was
performed as a last resort. However, some authors now suggest that due to the high
success rate and low morbidity of MMA surgery, as well as the low success rate of stage
I surgery, MMA can be considered a first line surgical treatment for OSA.32 Furthermore,
MMA is a multi-site surgery that addresses the often multi-site problem that is OSA.
Cephalometric and 3-dimensional computed tomographic analysis has shown that
retropalatal, retroglossal, and total airway volume increases in both antero-posterior and
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lateral dimensions following MMA surgery.16,33 The surgery accomplishes this by
physically expanding the facial skeletal framework, and along with it the associated soft
tissues of the pharyngeal walls.
MMA is described as a “telegnathic” surgery, as both the maxilla and mandible
are typically advanced to large degrees. The surgery consists of a LeFort I osteotomy of
the maxilla, along with bilateral sagittal split osteotomies of the mandible, after which
both jaws are advanced and rigidly fixated in their new, anterior positions. Genioplasty
may or may not be performed. The hyoid, soft palate, tongue, and other pharyngeal
tissues are brought forward along with the maxilla and mandible, which results in a total
increase in the velo-orohypopharyngeal airway.34

Figure 1. Maxillomandibular advancement (MMA) plus genioplasty, profile
view (Reprinted from Ronchi et al35)

MMA has been shown to be more effective than UPPP in the treatment of OSA.
In addition, MMA preformed in conjunction with UPPP has lower rates of success than

9

MMA performed in isolation.31 This suggests that MMA may be considered the surgical
treatment of choice for patients unable to tolerate CPAP for treatment of moderate to
severe OSA. Critics of the MMA technique propose that the surgery is too invasive to be
recommended for routine use. However, modern orthognathic surgery has been shown to
be a very safe procedure with low frequency of serious complications.36 It has been
demonstrated that facial skeletal deformities need not be present pre-surgically for OSA
patients to benefit from MMA,35 as telegnathic lengthening of the jaws consistently
produces an increase in upper airway volume by advancing the pharyngeal soft tissues, as
well as raising the hyoid bone.37

Objective Outcomes of MMA for Treatment of OSA
When referring to objective outcomes of MMA for treatment of OSA, the changes
in AHI (or sometimes RDI) are the primary outcomes considered. In recent years, many
studies have arisen that demonstrate the efficacy in MMA surgery for the treatment of
OSA. A retrospective study by Varghese et al38 demonstrated that 71% of patients in
their sample (n=24) had reduction of AHI below 10, with 42% of subjects reaching
AHI<5. Smatt et al39 studied a group of 18 patients who underwent MMA and defined
success as having a post-operative AHI of less than 15, with at least a 50% reduction
from initial AHI. Using these parameters, the success rate was 84%. Using a staged
surgical approach, Li et al40 demonstrated a high (>95%) success rate for the patients who
underwent MMA surgery (with success defined as post-operative RDI<20) after previous
soft tissue resection.
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A retrospective study was conducted at The University of Western Ontario in
201541 that examined the clinical outcomes of patients, treated by one surgeon in
London, Ontario, who underwent MMA for treatment of OSAS. Twenty-two patients (11
males and 11 females) were included in the sample. In this study, 86.4% of the patients
were determined to have had a successful result, with 36.4% of the sample obtaining a
cure of their OSAS after treatment, as determined by analysis of pre-treatment and posttreatment AHI scores. Daytime sleepiness was significantly reduced in 88.9% of patients.
Due to the relatively small sample size, no gender, surgical, anatomical, physiologic, or
cephalometric predictors of successful treatment were found in this patient population.
A systematic review conducted by Pirklbauer et al42 found success rates for MMA
ranging from 65% to 100%, depending on the criteria for success used, which varied
widely among the studies. Strict target success rates are helpful in qualifying success or
cure, and the authors recommend further follow-up studies to gauge the long-term
success of the treatment. Another review conducted by Holty et al43 found MMA to be a
highly effective treatment, with a combined surgical success rate of 86% (success defined
as AHI<10), and a cure rate of 66.7% (cure defined as AHI<5).
There is currently limited data on the long-term stability and success of MMA
surgery as a treatment for OSAS. This is concerning, given the tendency for skeletal
relapse following orthognathic surgery, particularly in cases where large skeletal
movements have been achieved. Most data regarding outcomes for MMA surgery focus
on the first year following the surgery. A study by Riley et al44 followed 40 patients for a
mean follow up period of 50.7 months (range 12-146 months). At long term follow up,
90% of patients had maintained reduction of their RDI to clinically successful levels
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(<20). Four patients (10%) did not experience the same success, but it is noteworthy that
these four patients experienced significant weight gain from the time of surgery to the
time of follow up. Also, the authors found that the reduction in RDI to be proportional to
the extent of the surgical movements; i.e. a larger advancement generally resulted in a
greater reduction in RDI post-surgically and in long-term follow up.
Another study of 6 patients by Jaspers et al45 examined the success of MMA
surgery for OSA treatment 8 years post surgically. Five of the 6 maintained a markedly
reduced AHI, although two remained above 5 and have been re-diagnoses with mild
OSA. The sixth patient relapsed from an AHI of 2 at six month post-surgery to an AHI of
42 at 8 years. This patient had an AHI greater than 80 initially. The main drawback of
this study is small sample sizes. Further studies examining the success of OSAS should
focus on long-term analysis of surgical success.

Subjective Outcomes of MMA for Treatment of OSA
Measures of success of MMA treatment for OSA must not only include the
objective parameters examined during polysomnography, but must also take into account
subjective measures, such as patient satisfaction. In patients considering MMA, it is ideal
if there are reasonable assurances that their quality of life will improve, and that they will
achieve a reasonable aesthetic result. It has been shown that in patients seeking routine
orthognathic surgery for treatment of dentofacial deformities, their levels of happiness
were significantly lower pre-surgically when compared with controls. This was especially
true in female, Class II patients.46 Following surgery, patients are known to experience
negative psychological changes in the immediate post-surgical period, such as
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depression, but in the long term the enhanced sense of aesthetic satisfaction seems to
mitigate this short-term depressive effect.47 It is likely that the transient deterioration of
quality of life can be attributed to surgical morbidities, which are generally temporary.48
Long-term, these patients generally remain satisfied with their treatment.49 Lye et al50
reported that 93.3% of their sample of patients who underwent MMA for the treatment of
OSA (n=15) had a successful quality of life change. Goodday and Bourque51 reported
that 89% of their sample (n=116) found the procedure to be worthwhile, and 95% would
recommend the procedure to others.
There have been a limited number of studies examining the objective outcomes of
MMA with respect to facial esthetics. It is important to note that while it is the hard
tissues that are moved by telegnathic surgery, it is the soft tissues that form the basis for
an aesthetic evaluation. In general, the soft-tissue to hard-tissue ratio of movement in the
upper lip, lower lip, and chin of patients undergoing MMA is about 0.9:1.52 Furthermore,
the goal of surgery is not simply to correct a dentofacial disharmony. It is typically
desirable to maximize the surgical movements to their greatest limits, so that maximum
anterior movement of the maxillomandibular complex is achieved and, thereby
maximally expanding the airway.53
A small number of studies have been published that specifically address facial
aesthetic outcomes of MMA surgery. Liu et al54 found that over 90% of patients in a
Chinese population responded favourably to their facial appearance after MMA surgery
for OSAS treatment. One hundred laypersons were also surveyed, and the aesthetic
scores given to 11 of the 12 patients were significantly higher for the post-operative
pictures. However, the sample size of this study was small (n=12), the sex distribution of
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the sample skewed (11 M, 1 F), and the photos assessed were unaltered save for blocking
out the eyes to protect the patients’ identities. It is possible that this may have introduced
confounding variables with respect to facial appearance that are difficult to control for.
Cohen-Levy et al55 looked at assessment of patients’ profiles by three groups: lay
persons, art students, and orthodontists. Fourteen out of fifteen patients were satisfied
with the aesthetic changes after surgery. The person who was dissatisfied noted worsened
appearance of the nose and upper lip. Eighty-five percent of post-operative profiles were
viewed as having changed favourably by the panel members, with no significant
differences amongst the three groups. The profiles that were assessed as being worsened
by surgery shared several common characteristics: prochelia of the lips (exceeding the Eline), visible closure of the nasolabial angle, a small-appearing nose, and short faces pretreatment. Profiles assessed as the most attractive had an obtuse nasolabial angle, with
marked labial retrusion. The authors suggest that retrocheilia and an open nasolabial
angle in the pre-operative profile may be predictors of successful MMA treatment from
an aesthetic perspective. They propose that this effect may be enhanced orthodontically
by adjusting the antero-posterior position of the incisors, and thus the upper lip, prior to
surgery.
A number of negative aesthetic sequelae have been reported following MMA,
including excessive maxillomandibular protrusion, bulging upper lip, prominent upper
incisors, and widening of the nose.56 It is therefore crucial to optimize surgical treatment
planning and execution to avoid incurring any of these effects, and to identify patients in
which particular caution must be employed. Though these difficulties sometimes occur,
high patient satisfaction with respect to post-surgical patient aesthetics has been
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reported.54 In a study by Li et al53, it was found that 90% of patients who underwent
MMA for treatment of OSAS reported neutral or positive changes to their facial
appearance. This was despite significant maxillomandibular protrusion as determined by
cephalometric analysis post-surgery. The authors used a visual analogue scale (VAS) for
the patients’ self-assessment. It was noted that while non-obese, younger patients with
thin facial soft tissues were at the greatest risk of adverse facial change, each case must
be assessed and diagnosed individually during surgical planning to avoid creating
unfavourable changes.

Patient Reported Outcome Measures
Positive patient outcomes are paramount to the success of any surgical procedure.
When discussing patients who undergo MMA for treatment of OSA, we are particularly
interested in outcomes relating to overall health and general quality of life, snoring,
daytime sleepiness, functional sleep outcomes, functional outcomes relating to
orthognathic surgery, and facial aesthetics. Currently, there is no single questionnaire
available that has been developed that addresses each of these domains for patients
undergoing MMA for treatment of OSAS specifically. Development of such a tool may
prove useful in not only assessing patient outcomes after treatment, but also to provide
patients with sound data to manage their own expectations, as well as to provide more
thorough informed consent prior to the treatment. There are a number of previously
validated health-based questionnaires that address each of these domains on their own.
The most commonly used generic health status measure that can be used to
measure outcomes in many different patient groups is the SF-36 short-form
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questionnaire, along with its abbreviated version, the SF-12. These questionnaires,
developed and validated in the United States, have been adopted as some of the main
standard outcome measures in America and around the world.57,58,59 The majority of the
questionnaire relates to the status of the patient’s life with respect to physical, emotional,
and social health. While most questions are too general to ascertain outcomes of MMA in
OSA patients, several of the questions regarding general health in well-being, especially
those comparing health now and before the operation, could be useful in determining the
patient’s perception of overall health in a question format that has been previously
validated.
There are a number of questionnaires that have been previously developed and
repeatedly validated that assess various sleep outcomes in OSA patients, with different
academic centers preferring to use specific ones. Several validated screening
questionnaires include the STOP and STOP-BANG Questionnaires,60,61 the Sleep-50
Questionnaire,62 and the Sleep Disorders Questionnaire.63 More commonly used
screening measures are the Berlin Questionnaire and the Epworth Sleepiness Scale.
The Berlin Questionnaire is the most widely used questionnaire specifically
developed for OSA patients.64 In addition to assessing daytime sleepiness, the Berlin
Questionnaire takes the patient’s age and weight into account, and includes measures for
snoring, hypopneas/apneas, and whether or not the patient has high blood pressure, which
has been positively associated with OSA.65 The patient’s height and weight allow the
investigator to calculate Body Mass Index (BMI). Snoring is not only correlated with
apneic events, but also may serve as indicator for surgical success, as enlargement of the
nasopharyngeal airway in theory will reduce the patient’s tendency to snore.
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The Epworth Sleepiness Scale is an 8-question questionnaire in which the subject
is asked to rate his/her likelihood of falling asleep during various scenarios, on a scale
from 0-3. An overall score is derived from the answers, with a score of 10 or higher
indicating excessive daytime sleepiness.4
The Functional Outcomes of Sleep Questionnaire (FOSQ)66 is a self-reported
measure intended to assess the functional outcomes of daytime sleepiness. It was
developed to determine how disorders of excessive sleepiness affect patients’ abilities
during daily activities. It consists of 30 questions, which ask the subject to rate the effect
their sleepiness has on various daily activities on a scale of 0-4. Along with the Epworth
Sleepiness Scale, it is one of the most commonly used self-reported measures to assess
daytime sleepiness. It was not developed for MMA patients, but several questions in the
FOSQ may be useful in assessing patients’ daytime sleepiness during normal activities
such as socializing with friends, exercising, and relaxing around the house.
The Orthognathic Quality of Life Questionnaire (OQLQ)67 was developed
specifically to assess quality of life in patients who are candidates for orthognathic
surgery, primarily those with dentofacial deformities. The questionnaire assesses
patients’ perceptions of their teeth and face, jaw function, and the social impact of these
variables. While it was not specifically designed for OSAS patients who are candidates
for MMA, it can easily be applied to assess QOL outcomes in these patients, especially
since older patients may be particularly sensitive to facial changes.
Other questionnaires that were not developed for orthognathic patients may also
be of value. The Glasgow Benefit Inventory (GBI)68 is a measure designed to assess the
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impact of otorhinolaryngological interventions such as tonsillectomy and rhinoplasty on
patients’ quality of life. The questions examine the impact of such procedures on overall
quality of life, self-confidence, and self-consciousness. The GBI uses factor analysis (a
technique involving the grouping of question responses to demonstrate overall trends) as
a defining feature, however this technique is not used in the present study. The validated
question forms from the GBI may be drawn upon to assess QoL in MMA patients.
The change in facial appearance following MMA surgery must be addressed as
part of informed consent. The literature about measures that assess subjective outcomes is
limited in orthognathics. The OQLQ contains some questions that measure aesthetic
satisfaction. The plastic surgery literature is more developed in this regard, and several
validated and widely used questionnaires exist that assess cosmetic outcomes after facial
surgery.
The FACE-Q Questionnaire is a very detailed measure that allows the patient to
express their opinions about every aspect of the face, such as their skin, lips, eyebrows,
etc. While it is very useful when assessing the aesthetic outcomes of plastic surgeries, it
is far too detailed for use in orthognathics because the surgery itself has a relatively
limited effect on external structures. The Facelift Outcomes Evaluation (FOE)69 is a 6question validated measure that is meant to screen patients for facelift procedures. The
first question, which is an assessment of overall facial appearance, may be applied to
patients undergoing MMA for treatment of OSAS, as well as a modified version of the
same question assessing patient satisfaction with the appearance of the facial profile.
Since MMA surgery is indeed often described as a “reverse facelift” due to soft tissue
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stretch over expanded skeletal structures, the use of a modified form of the FOE may be
useful in assessing aesthetic outcomes in MMA patients.
The Derriford Appearance Scale (DAS59)70 is a comprehensive general
questionnaire to measure the spectrum of psychological distress associated with having a
physical deformity or disfigurement. It was developed with far less severe deformities in
mind than those associated with dentofacial dysplasia, but nonetheless several measures
in the questionnaire may prove useful in orthognathics. In particular the questions
assessing the patients’ feelings of attractiveness and masculinity/femininity would be of
interest to MMA patients. In telegnathic MMA surgery, we are by definition lengthening
the jaws. Societal interpretations of a “strong jaw” are inherently masculine in nature, so
prospective female MMA patients in particular may be interested in whether or not the
surgery will make them “too masculine”.
With the increasing understanding of the health implications of OSA, it is likely
that the number of patients seeking MMA for treatment of their sleep apnea will increase
in the future. It would be useful to develop an outcomes measure specifically for these
patients. As patients considering this treatment have to consider the implications with
respect to multiple facets of their well-being, the questions in such a questionnaire would
need to address general quality of life, daytime sleepiness and functional sleep outcomes,
snoring, cosmetic facial outcomes, as well as functional outcomes of orthognathic
surgery. By using a composite of questions from the previously mentioned validated
questionnaires as a starting point, it may be possible to devise a measure that adequately
assesses patient-reported outcomes in such a way that will be useful to screen future OSA
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patients for MMA, as well as to assess the outcomes of MMA in the treatment of OSA
and assess overall patient satisfaction with the treatment.
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Introduction
Obstructive Sleep Apnea (OSA) is a common but often unrecognized disorder
that has a significant detrimental effect on patient quality of life.1 OSA is associated with
a number of other conditions, such as diabetes,12 metabolic syndrome,13 and
cardiovascular disease.14 There is a strong correlation between OSA and Body Mass
Index (BMI).11 Other sequelae like hypersomnolence, cognitive dysfunction, impaired
work performance, and increased irritability are also seen in individuals with OSA.9
Various treatment modalities are available to OSA patients. Overweight patients
are typically recommended to lose weight. The gold standard treatment is continuous
positive airway pressure, or CPAP, in which a machine blows air into the nose,
increasing the pressure within the pharynx, thus maintaining airway patency during sleep.
While CPAP has been shown to be an effective treatment,22 patient compliance is often
an issue as nasal congestion, oral and pharyngeal dryness, skin rash, and complaints from
partners are often cited as reasons for not wearing the machine. Oral appliances to
advance the mandible may be effective in mild to moderate OSA cases, although they
address only the retroglossal site of airway obstruction and may have deleterious dental
side effects.25
For many years, pharyngeal soft tissue (Stage I) surgery was the most common
method of dealing with OSA surgically, with the uvulopalatopharyngoplasty (UPPP)
being the most commonly employed technique.28 It has been shown that UPPP is, at best,
50% successful,29 and that common negative sequelae include hypernasal speech, nasal
reflux, and nasal airway obstruction due to scar tissue formation from the surgery itself.2
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Maxillomandibular advancement (MMA) has been traditionally designated a
second stage surgery due to its perceived invasiveness, however it is becoming more
popular as a first-line surgical treatment as its apparent advantages come to light. It has
been shown to be a more effective OSA treatment with UPPP,31 as it addresses both the
retopalatal and the retroglossal areas of potential airway obstruction. Because of this,
MMA is often referred to as “telegnathic” surgery, as both jaws are effectively
lengthened.
MMA has shown to be an effective treatment that leads to an objective
improvement in OSA symptoms.38-43 A study conducted at the University of Western
Ontario’s in 201541 found that of 22 OSA patients treated with MMA by a single surgeon
at LHSC, 86.5% had successful treatment with significant AHI reduction as well as
reduced daytime sleepiness. However, the literature dealing with subjective outcomes of
MMA in OSA patients is limited.
With any treatment procedure, subjective measures of success must be
considered, in particular those that pertain to the patient’s quality of life (QoL). Any
procedure that has the potential to have a detrimental effect on QoL must be approached
with caution. Uncovering predictors of post-treatment QoL in these patients has the
potential to be helpful in screening patients who are candidates for MMA surgery, as well
as to provide the opportunity for appropriate informed consent.
When considering MMA for treatment of OSA, we must consider the patient’s
perceptions when it comes to sleep outcomes such as daytime sleepiness and restfulness,
as well as snoring and apneic events during sleep. The latter outcomes are usually
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assessed by assessing the patient’s partner, or someone else who can observe the patient
while he/she is sleeping.
While the functional outcomes of orthognathic surgery have been well
documented among patients with dentofacial deformities, there is little literature available
that examines these outcomes with respect to OSAS patients specifically. The previously
mentioned article by Phee41 concluded that the procedure may be completed while
avoiding any major complications, but data regarding quality of life in the peri-operative
period for MMA patients specifically is limited. Goodday et al51 found that most patients
are satisfied with the procedure in the long term and would recommend it to others. It
may be useful to explore this area to determine if patients undergoing MMA for treatment
of OSAS deem the surgical process as being “worth it”. Potential long-term
considerations for those undergoing orthognathic surgery include numbness, jaw and/or
facial pain, and difficulties with mastication.
Facial esthetic change is an outcome that has the potential to greatly affect a
patient’s self esteem and confidence. While facial change is expected and often desired in
conventional orthognathic patients who are receiving treatment to correct an underlying
dentofacial deformity, it is often desirable to minimize facial changes in adult patients. It
is reasonable for an adult patient to inquire as to what they will look like after surgery.
The majority of patients who undergo orthognathic surgery are satisfied with the changes
in their facial appearance.71 However, since in most cases, patients undergoing MMA for
OSA treatment are concerned with aesthetics only secondarily to their sleep disorder,
these patients may be more sensitive to large changes in facial appearance.51 Therefore,
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an effort must be made to optimize aesthetics in MMA cases, while ensuring enough
advancement is performed as to allow for improvement in OSA symptoms.
As MMA becomes increasingly common for the treatment of OSA, it is of critical
importance patients understand the effects the results of the surgery may have on their
quality of life not only generally, but specifically with respect to facial aesthetics,
snoring, daytime sleepiness, and functional sleep outcomes. Functional outcomes of
orthognathic surgery, such as masticatory function, should also be assessed. There are
already validated measures that assess these areas specifically. For example, the
Functional Outcomes of Sleep Questionnaire (FOSQ)66 and Epworth Sleepiness Scale4
address daytime sleepiness and its effect on daily activities, the Berlin Questionnaire65
addresses snoring, and the Orthognathic Quality of Life Questionnaire (OQLQ)67 deals
with subjective facial appearance after orthognathic surgery, among other functional
surgical outcomes. By using a modified composite of these and other measures, it may be
possible to construct a questionnaire that is able to assess subjective patient outcomes for
OSA patients undergoing MMA in the areas mentioned above.
Purpose of the Study
There is clearly a need for more study into subjective patient outcomes in OSA
patients following MMA. Therefore, the aim of this study is to assess general quality of
life, snoring, daytime sleepiness and functional sleep outcomes, functional outcomes of
orthognathic surgery, and facial aesthetic outcomes in a group of patients who underwent
MMA surgery for the treatment of OSA.
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Materials and Methods

Ethics Approval
Ethics approval was obtained from both the Health Sciences Research Ethics
Board (HSREB) at Western University (approval number R-15-286), as well as the
Lawson Institute at the London Health Sciences Center (LHSC)(file number 106869)
(Appendix I).
Study Participants
The potential participants in this study were 32 patients who underwent
maxillomandibular advancement surgery by a single oral and maxillofacial surgeon at
LHSC between the years 2002 and 2013. The inclusion criteria included having a presurgical AHI greater than 5 as determined by a sleep study, that they underwent the
procedure during the aforementioned time frame, and that they were able to be contacted
to participate in the survey. Exclusion criteria included patients who could not be
contacted prior to distributing the survey, patients with other sleep disorders other than
OSA, or patients whose pre-surgical AHI was less than 5, and thus could not be
diagnosed with OSA.
Development of the Questionnaire
A review of the literature was conducted to examine validated measures that
assess general quality of life, quality of life related to orthognathic surgery, sleep-related
quality of life and outcomes, as well as facial cosmetic and aesthetic outcomes. A
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questionnaire was devised using modified questions from several previously validated
measures including the SF-3657, the Orthognathic Quality of Life Questionnaire
(OQLQ)67, the Epworth Sleepiness Scale (ESS)4, the Functional Outcomes of Sleep
Questionnaire66, the Berlin Questionnaire65, Derriford Appearance Scale70, and the
Facelift Outcomes Evaluation.72 A number of original questions that were designed to
assess subjective patient outcomes not touched on the above measures were included as
well. (Appendix III). The majority of the questions were constructed using five
categories, from most positive to most negative outcome, with the middle (third) outcome
being interpreted as neutral. Several questions had two potential responses (yes/no, for
example). The Epworth Sleepiness Scale was included in its original format. A number of
questions provided text space for the patients to elaborate on their answers, if desired. For
all questions, an option of “I don’t know” was provided for the patients to select should
one of the other provided answers not apply to them.
The first series of questions were meant to assess the patients’ overall state of
health and well-being. Question one was derived form the SF-36 questionnaire, while
questions two, three, four, and five were original questions added by the author. Question
six is the Epworth Sleepiness Scale in it’s original, unaltered format. Questions seven and
eight were added to determine the patients’ current height and weight, so that current
BMI values could be calculated. Questions nine through 14 were derived from the Berlin
questionnaire, and were included to assess snoring outcomes. Questions 15 through 22
were intended to assess functional sleep outcomes, and were derived from the functional
outcomes of sleep questionnaire (FOSQ).

26

Questions 23, 24, 26, 27, 28, and 29 were derived from the Orthognathic Quality
of Life Questionnaire (OQLQ), and were added to address functional surgical outcomes.
Question 25 was an original question added by the author to assess the extent of
persistent numbness present after surgery.
The next series of questions addressed facial aesthetic outcomes, and were
derived from the OQLQ, the Facelift Outcomes Evaluation (FOE), the Derriford
Appearance Scale, as well as some original questions. Questions 30, 31, and 32 were
derived from the OQLQ. Questions 33 and 34 were derived from the FOE, and question
35 was derived from the Derriford Appearance Scale.
The final series of questions (36 through 40) were intended to address the
patients’ overall quality of life, as well as their satisfaction with the treatment. All were
original questions added by the author, as the variables addressed by these questions
could not be retrieved from an existing validated questionnaire.
Content Validation
The questionnaire was pre-tested by distributing it to five individuals, none of
who had a diagnosis of sleep apnea, to verify the clarity of the questions. The testers were
asked to provide feedback regarding the wording and clarity of the questions, as well as
feedback regarding the overall format of the survey. Minor grammatical and structural
changes were applied to the survey after feedback from these individuals.
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Distribution of the Questionnaire
The participants were initially contacted by the surgeon who provided their
treatment. Up to date e-mail and home addresses were obtained over the phone. The
survey as well as the informed consent form was distributed to the participants either by
e-mail or standard mail, according to their preference. After one week, non-responders
were sent a reminder e-mail with an additional link to the survey. This process was
repeated once more for persistent non-responders, so the maximum number of times the
patients could be sent a survey was three, as per the Dillman methodology73 for online
surveys. If after three attempts the patients did not respond, they were deemed nonresponders and were not sent any additional surveys.
The survey was created and distributed using Qualtrics® survey software
(Qualtrics, Provo, UT). The data from the returned questionnaires was stored within the
Qualtrics® software on encrypted servers at The University of Western Ontario. For the
participants who requested to be sent the questionnaire via regular mail, an addressed
return envelope with postage to the department of Oral and Maxillofacial Surgery at
University Hospital (LHSC) was provided. The data from these questionnaires was then
entered manually by the author into the Qualtrics® software.
Informed Consent
An informed consent form was created using guidelines from the Health Sciences
Research Ethics Board (HSREB) at The University of Western Ontario (Appendix II). An
electronic version of this form was made available to the respondents before completing
the survey electronically, or it was sent along with the survey for those patients who
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requested to complete the survey via standard mail. In the electronic copy, the
respondents were asked to click a box to indicate they have given informed consent for
the study. Participants who were mailed the form along with the questionnaire were asked
to send the signed and dated informed consent form back along with the completed
questionnaire.

Statistical Methods
Data analysis was completed using SPSS statistical software program (Released
2014. IBM SPSS Statistics for Windows, Version 23.0. Armonk, NY:IBM Corp).
Descriptive statistics were generated along with tables for each question in the survey.
Chi-square tests and ANOVAs were performed to assess any potential associations
between the questionnaire responses and various demographic and other respondent
variables. Fisher’s exact test was used when the assumptions for chi-squared tests were
not met. The responses for several question groups, such as daytime sleepiness and
functional sleep outcomes, snoring outcomes, and facial aesthetic outcomes were
condensed and combined in SPSS. Chi-square tests were run to look for significant
associations between these outcomes and overall quality of life. Statistical significance
for all tests was set at a P-value <.05.
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Results

Patient Demographics
Of the 32 potential participants, two were excluded from the study because they
could not be contacted. One patient was not included as he was diagnosed with CSA in
conjunction with OSA, making him unsuitable for a surgical correction. A further four
patients were excluded as their AHI scores were not high enough for a diagnosis of OSA,
and thus did not satisfy the inclusion criteria. Out of the 25 surveys distributed, 22 (88%)
were returned. No significant differences with respect to sex or age were found between
responders and non-responders (p>.05). Eleven (50%) of responders were female and 11
(50%) were male (Table 1). The mean age at the time of survey completion was 48.8 (+/13.2) years, with a range of 19.4 to 65.5 years (Table 2). All surveys were completed in
October of 2015. The mean time from the surgery date to the time of survey completion
was 6.4 (+/- 3.5) years with a range of 1.8 to 13.4 years (Table 2).
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Frequency
Sex:
Male
Female
Total
Ortho:
Yes
No
Total
AHI success:
Yes
No
Total
Missing
Pre AHI:
Mean
Range
Post AHI:
Mean
Range
AHI change:
Mean
% AHI change:
Mean

Percent
11
11
22

50.0
50.0
100.0

17
5
22

77.3
22.7
100.0

15
2
17
5

68.2
9.1
77.3
22.7

48.4
11.5-120.0
12.5
1.0-59.4
-36.1
-68.2

Table 1. Sex demographics of the survey responders, as well as the number that did
and did not have orthodontic treatment, and those that did and did not have
successful AHI reduction after surgery. The mean pre and post-surgical AHI values,
as well as the mean AHI change is demonstrated.
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Of the 22 responders, 17 (77.3%) had orthodontic treatment in conjunction with
their surgery, while 5 (22.7%) did not (Table 1). The average BMI at the time of survey
completion was 28.8 (+/-6.6), with a range of 20.2 to 46.1 (Table 2).
Age (years):
Mean
Std. Deviation
Range
Current BMI:
Mean
Std. Deviation
Range
Time Since Surgery (years):
Mean
Std. Deviation
Range

48.8
13.2
19.4-65.5
28.8
6.6
20.2-46.1
6.4
3.5
1.8-13.4

Table 2. Current age, BMI, and time since surgery for the 25 survey respondents
Of the 22 participants, only 17 had post-surgical AHI scores, so AHI success
(defined as a post-surgical AHI of 15 or less, or a post-surgical AHI reduction of 50%)
could only be determined for these patients. Of the 17 participants with available postsurgery AHI scores, only 2 (9.1%) did not have a successful result with respect to AHI
reduction. Thus, the success rate for this sample was 90.9%. The mean pre-surgical AHI
was 48.4, the mean post-surgical AHI was 12.5, and the mean AHI change was -36.1 (68.2%)(Table 1).
Questionnaire Results
Please refer to Appendix IV for detailed tables and results for all questions.
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Questions one through three were meant to assess the general health of the
patients. Sixteen (72.7%) of participants rated their health as “excellent” or “very good”,
while the rest rated themselves as “good” or “fair”. Nineteen (86.4%) of participants
rated their health as either somewhat or much better than the time before surgery, two
(9.1%) rated their health as about the same, while one (4.5%) participant rated their
current health as worse than the time before their surgery. Several of the participants
were diagnosed with new medical conditions since the time of surgery, including ADHD
(n=1), hypertension (n=2), and Celiac disease (n=1). One patient indicated that they are
being investigated for Parkinson’s disease, but that they do not yet have a definitive
diagnosis.
Twenty-one (95.5%) of the patients reported their sleep apnea got better since
having the surgery, while none reported worsening of their OSA symptoms (Question
four). Twenty-one (95.5%) of the participants report wearing a CPAP machine “never or
nearly never”, while one (4.5%) reported continued nightly CPAP wear (Question five).
The mean Epworth Sleepiness Scale value for the participants was 4.0 +/- 3.3 with a
range of 0-14, with one patient (4.5%) having an ESS score above 10, which indicates
clinically significant daytime sleepiness (Question six). Questions seven and eight asked
the participants to provide their current height and weight so that BMI scores could be
calculated.
Questions nine through 14 addressed snoring outcomes. Nine (40.9%) of the
participants report snoring rarely, or never (Question nine). Most participants report that
their snoring is not as loud as the time before surgery, and that it bothers other people less
than it did before having surgery (Questions 10, 13, and 14). Eleven (50.0%) participants
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reported that they experienced cessations in breathing during sleep rarely or never
(Question 11), while 15 (68.1%) of participants claim to snore less than they did before
surgery (Question 12). More participants selected “I don’t know” as an answer option in
this section than in other sections, indicating that they are not aware of their sleep
behavior. The responses from 12 through 14 we combined to demonstrate the percentage
of positive, negative, and neutral responses recorded for snoring variables (Table 3).

# of responses

Snoring Outcomes
100
80
60
40
20
0

94
55

Positive

Neutral

15

12

Negative

I don't
know/No
response

Response Categories

Table 3. Percentage of Negative, Neutral, and Positive Responses in the
Questions That Addressed Snoring Outcomes (12 through 14)
Questions 15 through 22 assessed daytime sleepiness, as well as the effect of
sleepiness on daily functioning. Nineteen (86.4%) of responders reported feeling more
refreshed in the morning compared to the time before surgery (Question 15), 19 (86.4%)
participants reported feeling less tired during the daytime (Question 16), and 20 (90.9%)
reported that the quality of their sleep is better compared to the time before surgery
(Question 17). Fifteen (68.2%) reported having less difficulty socializing compared to
the time before surgery, 17 (77.3%) report having less difficulty concentration or
remembering things, 19 (86.4%) reported less difficulty doing chores or exercising, and
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19 (86.4%) reported less difficulty sitting through movies or lectures without difficulty
(Questions 18 through 21). Sixteen (72.7%) of the participants reported their mood being
less affected by sleepiness compared to the time before surgery. The results from
questions 15 through 22 were compiled to demonstrate the percentage of positive,
negative, and neutral responses recorded for daytime sleepiness and functional variables
(Table 4).

# of responses

Daytime Sleepiness and Functional
Sleep Outcomes
100
80
60
40
20
0

94
55

Positive

Neutral

15

12

Negative

I don't know/No
response

Response Category

Table 4. Percentage of Negative, Neutral, and Positive Responses in the
Questions That Addressed Functional Sleep Outcomes (15 through 22)
Questions 23 through 25 address specific aspects of the participants’ quality of
life as it pertains to the orthognathic surgery itself. Eleven (50.0%) reported having fewer
problems with biting and chewing than the time before surgery, while five (22.7%)
reported more problems (Question 23). There was no significant relationship between
problems with chewing and/or bite and orthodontic therapy (P>0.05). Seven (31.8%)
reported less TMJ and facial pain than before surgery, seven (31.8%) reported more pain,
while 6 (27.3%) reported no difference (Question 24). Eighteen (81.8%) of participants
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reported partial or complete resolution of numbness from the time of surgery (Question
25).
Questions 26 through 35 assessed the aesthetic facial outcomes of the surgery, as
well as the psychological and social impact of these outcomes. Nine (40.9%) reported
having more confidence when out socially, while two (9.1%) reported having less
confidence (Question 26). Eleven (50.0%) reported feeling less self-conscious about their
facial appearance than before surgery (Question 27), and 11 (50.0%) reported feeling less
self-conscious about the appearance of their teeth and smile (Question 28). Six (27.3%)
of participants reported spending more time studying their face in the mirror than the time
before surgery (Question 29).
Twenty (90.1%) reported liking their frontal facial appearance the same or more
than the time before surgery (Question 30), while one (4.5%) liked it less. Seventeen
(77.3%) reported liking their appearance in profile the same or more (Question 31), while
17 (77.3%) believed that their family and friends like their facial appearance as much or
more than the time before surgery (Question 32).
Nine (40.9%) respondents believed that the surgery made them look younger,
while two (9.1%) believed that it made them look older (Question 33). Fourteen (63.6%)
believed that the surgery made them look more attractive, four (18.2%) believed it had no
effect on attractiveness, and two (9.1%) believe the surgery made them look less
attractive (Question 34). One (4.5%) participants thought the surgery made them look
more feminine, 4 (16%) thought the surgery made them look more masculine, while 15
(68.2%) reported no difference with respect to masculinity/femininity (Question 35).
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Broken down by sex, four (18.2%) men found the surgery made them appear more
masculine, while none indicated that the surgery made them look more feminine.
Similarly, one (4.5%) female thought the surgery made her look more feminine, while no
females indicated that the surgery made them appear more masculine. Questions 26, 27,
28, and 30 through 34 were combined to demonstrate the percentage of positive,
negative, and neutral responses collected with respect to facial aesthetic outcomes (Table
5).

Facial Aesthetic Outcomes
# of responses

100

94

80
55

60
40
20

15

12

Negative

I don't know/No
response

0
Positive

Neutral

Response Category

Table 5. Percentage of Negative, Neutral, and Positive Responses in the
Questions That Addressed Facial Aesthetic Outcomes
The remaining questions were meant to assess the effect the surgery had on the
participants’ overall quality of life. Nineteen (86.4%) of the participants reported that
their quality of life is better now than the time before the surgery (Question 36). Eighteen
(81.8%) said their experience with the treatment was worthwhile (Question 37). Sixteen
(72.7%) of the patients reported that they would go through the procedure again, while
two (9.1%) reported that they wouldn’t (Question 38). Seventeen (77.3%) reported that
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they would recommend the procedure to their family and friends, if needed (Question
39).
Chi Square testing revealed positive associations between question 36 (subjective
assessment of overall QoL) and snoring outcomes (p=0.001) and functional outcomes of
sleep (p=0.003). Functional sleep outcomes were not significantly associated with
snoring outcomes (p=0.084). Facial aesthetic outcomes were not found to be significantly
related to overall QoL (p=0.818) and snoring outcomes (p=0.723), but were found to be
significantly associated with functional sleep outcomes (p=0.046) (Table 6).

Quality of life improved? Q36
Snoring Outcomes
Functional Sleep Outcomes
Facial Aesthetic Outcomes

QoL Improved?

Snoring

Functional Sleep

Aesthetics

X
0.001*
0.003*
0.818

0.001*
X
0.084
0.723

0.003*
0.084
X
0.046*

0.818
0.723
0.046*
X

Table 6. Associations between general QoL, snoring outcomes, daytime sleepiness
and functional sleep outcomes, and facial aesthetic outcomes along with
corresponding p values. *p<.05

Sex
There were statistically significant differences in several question responses with
respect to patient sex. Females preferred their appearance in profile after surgery to males
(p=.049), and females also felt significantly more attractive compared to males postsurgery (p=.043)(Table 7).
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Question
Q31: Since having surgery, how do you like the
appearance of your face from the side (profile)?
Q34:Do you feel like having orthognathic
surgery has made you more, or less attractive?

Less
Same
More
Less
Same
More

Male
0
4
7
0
4
6

Female
2
0
8
2
0
8

p-value
0.049*

0.043*

Table 7. Statistically significant associations relating patient sex to various survey
question responses. *p<.05

Orthodontic Treatment
More than twice as many patients were treated orthodontically in conjunction with the
surgery than those who weren’t (Table 1). Patients who were treated orthodontically
reported to be significantly les self-conscious about their facial appearance (p=.009) and
about the appearance of their teeth and smile (p=0.001). Patients who had orthodontics
also liked their frontal facial appearance (p<.001) and their appearance in profile
(p<.001) more than the patients who did not undergo orthodontics. Orthodontically
treated participants also felt more attractive post-surgery than those who did not receive
orthodontics (p<.001), and orthodontically treated patients also felt that their family and
friends approved of their post-surgical facial appearance when compared to patients who
did not receive orthodontics (p=0.033)(Table 8).
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Question
Q27:Since having your surgery, are you more, or
less self-conscious about your facial appearance?
Q28: Since having your surgery, are your more, or
less self-conscious about the appearance of your
teeth and smile?
Q30: Since having your surgery, how do you like
the appearance of your face from the front?
Q31: Since having surgery, how do you like the
appearance of your face from the side (profile)?
Q32: Do you feel that your family and friends like
your facial appearance more, or less since having
surgery?
Q34: Do you feel like having orthognathic surgery
has made you look more, or less attractive?

More
No diff.
Less
More
No diff.
Less
Less
Same
More
Less
Same
More
Less
Sane
More
Less
Same
More

Yes
3
3
11
3
3
11
1
1
15
1
0
16
1
1
12
1
1
14

No
2
5
0
1
5
1
0
7
0
2
5
0
1
5
1
2
4
1

p-value
0.009*

0.001*

<0.001*

<0.001*

0.033*

<0.001*

Table 8. Statistically significant associations relating whether or not the respondents
had orthodontic treatment to various survey question responses. *p<.05

AHI Success
There were no statistically significant associations found between AHI
success/failure and other patient reported outcome variables.
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Discussion
Obstructive sleep apnea is an increasingly common condition among people of all
age groups, and has a potentially serious detrimental effect on quality of life for these
individuals. While many treatments are available for OSA, none are as effective as
maxillomandibular advancement (MMA) surgery as a definitive treatment to reduce
AHI.44 The facial aesthetic outcomes have also been shown to be generally positive.53 It
is important for patients considering MMA to have reasonable expectations with respect
to their quality of life after the procedure. General QoL outcomes, daytime sleepiness,
functional sleep outcomes, snoring outcomes, functional surgical outcomes and facial
aesthetic outcomes must all be considered for these patients. Therefore, this study was
done to assess patient quality of life after MMA for the treatment of OSA.
The World Health Organization (WHO) defines health not only in terms of the
absence of disease, but must include a state of mental and social well-being74.Thus, when
assessing outcomes of any medical intervention, it is important to consider subjective
patient outcomes, in addition to objective outcomes. With respect to MMA for the
treatment of OSA, it is the patient’s own quality of life we are seeking to improve, thus
this is what we must seek to measure with our survey. Objective measures for assessing
OSA include AHI and RDI scores, however positive outcomes with respect to these
measures do not necessarily translate to positive outcomes as perceived by the patient. It
is conceivable that even if a person has a successful treatment with respect to objective
measures like AHI, that they may perceive an overall negative experience due to
unwanted facial changes, surgical complications, etc. It is therefore necessary to include
subjective patient outcomes in the parameters by which we define successful treatment.
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Maxillomandibular advancement for the treatment of obstructive sleep apnea
appears to have an effect on the quality of life for patients who undergo MMA for
treatment of OSA. The outcomes regarding daytime sleepiness, as well as functional
sleep outcomes are consistent with the literature. Most patients report never needing to
use CPAP (n=21, 95.5%), which is typical in patients who undergo this procedure.51 It is
worth noting that the patient who still relies on CPAP nightly experienced significant
weight gain, going from a BMI of 38.7 post-surgery to 46.1 at the time of survey
completion, which may have resulted in a relapse of his OSA. He had a successful
reduction in AHI after his surgery, as well as a successful reduction in ESS score in the
time after his surgery. Since he is still using CPAP, his current ESS score was 0. It would
be interesting to ascertain what his ESS score is in the absence of CPAP use, although it
may not be an ethical to do so.
Patients who had successful surgical results reported that in addition to having
improvement in their OSA symptoms, their overall health was better now than before
having surgery. The association between OSA and other comorbidities is well
documented.12-14 It is possible that by ameliorating the OSA symptoms, the risk of
developing these comorbidities went down in the successful patients, although a more
detailed assessment of each patient’s health today would be required as there are a large
number of contributing factors to overall health. The effect that MMA has in OSA
patients in decreasing blood pressure was demonstrated by Islam75 in a 2015 study. A
marked decrease in blood pressure was observed, especially in those patients who had
established hypertension before surgery. This suggests that MMA may have the potential
to reduce the severity of other comorbidities associated with OSA. Further studies should
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focus on the long-term effects that MMA has on conditions like diabetes mellitus,
metabolic syndrome, and cardiovascular disease.
One patient was not included in the study because he was diagnosed with central
sleep apnea (CSA) in conjunction with OSA, and thus was not a good candidate for
surgical correction. This participant was the only patient in the sample to have a
diagnosis of CSA, indicating that his apneic events are not caused by upper airway
obstruction, but rather a centrally mediated lack of respiratory effort. CSA is present in
up to 10% of patients with sleep disorders, and is commonly found in elderly men and in
those with poorly-controlled heart failure.76 CSA is often difficult to diagnose because
true apneas often mask CSA-related episodes during sleep studies.
The questions regarding snoring were derived in modified form from the Berlin
Questionnaire.65 Nine (40.9%) of the patients reported that currently they do not snore at
all, and the ones that do still snore report doing so much less than they did before having
surgery. The patients who still snore also report their snoring as much quieter than it was
before surgery, and that it bothers other people less. The effect that MMA has as a
telegnathic procedure effectively increases the volume of the oropharynx as the soft
palate is carried anteriorly with the maxilla, and this effect on the reduction of snoring is
well documented.39 There were more respondents who selected “I don’t know” or did not
respond to the questions in the survey that dealt with snoring (Questions 9-14). This may
be due to the fact that those people do not sleep in the same room with others, or their
partners might be deep sleepers. It is not known from the survey data which participants
have sleeping partners on a regular basis, and it may be useful to ascertain this
information in future surveys.
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The following questions addressed functional outcomes of sleep (daytime
sleepiness), and were mostly derived from the Functional Outcomes of Sleep
Questionnaire,66 in addition to the Epworth Sleepiness Scale4. The mean ESS score from
the survey was 4.0+/-3.3, and only one respondent scored above 10, which is the
threshold for clinically significant daytime sleepiness. Despite this, this patient reported
positive or neutral outcomes in the other questions addressing functional outcomes of
sleep, including Question 16, which directly addresses daytime sleepiness. This patient
would benefit from a sleep study to ascertain the current status of their OSA. The
majority of patients did have positive or neutral responses regarding these outcomes,
including feeling more refreshed in the morning, less sleepy during the daytime, and
better quality of sleep.
The majority of respondents reported less difficulty in social situations, less
difficulty remembering things and concentrating on tasks, and less difficulty doing
various forms of physical activity (Questions 18 through 20). These findings are similar
to those of Lye et al50, which noted that 93.3% of patients in their sample had positive
QoL outcomes after MMA for the treatment of OSA when using the FOSQ as their
primary measure. The original FOSQ uses a 0-4 Likert scale and includes 5 sections
meant to assess various domains of day-to-day life, including general activity levels,
vigilance, intimacy and sexual relationships, general productivity, and social outcomes.
When designing this questionnaire, an effort was made to include at least one question
type from each of those domains. The questions selected for use in this survey were
modified to a standardized 5 category (plus one “I don’t know” category) scaled
multiple-choice format.
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In their raw forms, the ESS and FOSQ should produce agreeable results with
respect to daytime sleepiness. It is possible that in changing the format of the questions,
they may have lost some validity, but this is likely not the case. The questions used were
constructed using blunt and straightforward wording, keeping with the original wording
from the various source questionnaires as much as possible. Therefore, the questions may
be said to have a degree of face validity, so formal validation may not be required as the
questions are very close to their original formats.
If a formal validation process was desired, a number of steps would be
undertaken, starting with establishment of face validation by having experts in the field
evaluate the questions for clarity. Then, a pilot test of the questionnaire is performed on a
sample of the intended population. This would be extremely difficult when assessing
OSA patients undergoing MMA, as there aren’t many of these patients to begin with.
After pilot testing, the gathered statistical data is cleaned and entered, principle
component analysis is performed to combine or eliminate questions that assess the same
outcome, and a number of statistical tests (e.g. Cronbach’s Alpha) are run to determine
the consistency of the questions in assessing their intended variables. Pilot testing is then
performed again and the process is repeated as needed.78
There were no statistically significant associations found between whether or not
the respondents had successful reduction of their AHI scores after surgery and the other
patient reported outcome variables considered in this study. One would think that
successful AHI reduction would be associated with positive sleep and snoring outcomes,
however this could not be demonstrated statistically in our population. This is likely due
to the small sample size in this study and the low number of reported failures with respect
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to AHI (n=2). In other words, there is significant risk of type II error, i.e. false negative
results in this study. Future research should utilize larger populations for increased study
power, and to minimize risk of beta-error.
The Orthognathic Quality of Life Questionnaire79 is a widely used measure to
assess patients’ qualities of life who have undergone orthognathic surgery. It has
traditionally been used to assess individuals who have undergone orthognathic surgery as
part of routine combined orthognathic/orthodontic therapy to address dentofacial
deformity and malocclusion.80 The primary motivation for treatment for OSA patients is
generally different from conventional orthognathic patients. While those suffering from
OSA may or may not have an underlying dentofacial deformity, their primary motivation
for treatment is typically to seek improvement of their OSA symptoms. Nevertheless,
these patients should have reasonable expectations of the experience and outcomes of
having orthognathic surgery as part of informed consent. It was deemed worthwhile to
address several variables that relate to the experience of orthognathic surgery to our
sample. The OQLQ has four components. Component one deals with social aspects of
deformity, for example self-consciousness. Component two deals with facial aesthetics,
component three addresses function, and component four addresses awareness of the
facial deformity. An additional original question was added in this section to address the
issue of persistent facial numbness after surgery. Questions 23, 24, and 26 through 31 are
derived from the OQLQ.
The functional variables assessed included potential problems with mastication,
facial pain, and numbness. Eleven (50.0%) reported fewer problems with mastication
than before surgery, while five (22.7%) reported more problems (Question 23). This is

46

somewhat contrary to previous research that has demonstrated a strong positive effect of
orthognathic treatment on mastication,81 however the small sample size in this study
makes it difficult to draw any definitive conclusions. Interestingly, there was no
significant association found between orthodontic treatment and chewing/bite issues after
surgery. It would have been expected that those receiving orthodontics had less
discomfort associated with their bite, however this was not the case.
Seven (31.8%) reported more pain in their face, jaws, and TMJs after surgery,
while seven (31.8%) reported less pain (Question 24). This is consistent with the
literature82, which shows that orthognathic surgery is neutral with respect with TMD, i.e.
it is not known to improve nor worsen TMD symptoms. In a 2013 study, Sanders et al83
demonstrated a link between TMD and OSA, as patients with 2 or more signs of OSA
were found to have a 73% greater incidence of TMD than in the control group. Although
the physiology underlying this association is not yet clear, it has been hypothesized that
OSA patients have high rates of nocturnal bruxism which may lead to TMD symptoms. It
is been hypothesized that these patients posture their mandible forward during sleep to
maintain airway patency,84 and that stress secondary to OSA leads to an increase in
bruxism and TMD symptoms. However, there is currently no strong evidence that clearly
defines the association between OSA and TMD.
Question 25 addressed facial numbness as a result of the surgery. Only three
patients (13.6%) reported significant persistent numbness in their face at the time of
survey completion. This is consistent with previous research that reports that significant
long-standing numbness occurs in as low as 3% of orthognathic cases.36
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One participant who was very disappointed with the results of her surgery cited
persistent numbness as a major reason why. She reported that the numbness causes her to
be uncomfortable in social situations, especially when eating. She also cited jaw
“cracking” and pain while functioning. Due to these factors, she indicated that she would
not undergo the procedure again. Despite this, she had overall positive sleep and snoring
outcomes.
The data from Questions 26 and 27 indicate that the majority of participants had
positive or neutral responses with respect to social confidence and self-consciousness. A
single respondent, mentioned above, indicated that she has “much less confidence” in
social situations, while nine (40.9%) reported an increase in self-consciousness regarding
their facial appearance and smile. Of these nine, only two were dissatisfied with their
facial appearance, so it may be that going through MMA treatment has simply made
these individuals more aware of their facial appearance. The data from Question 29 show
that six respondents spend more time studying their face in the mirror, so it may be that
undergoing MMA causes an increase in self-awareness regarding dentofacial appearance.
This has been demonstrated in patients seeking conventional orthognathic surgery,85 but
hasn’t been observed in OSA undergoing MMA.
The great majority of patients reported either positive or neutral changes with
respect to frontal facial and profile appearance, with 20 (91.0%) of respondents reporting
improvement or no change in the former and 17 (77.3%) reporting improvement or no
change in the latter. The majority of respondents also believed that their friends and
family have positive or neutral feelings regarding their facial appearance after surgery.
This is consistent with the current body of evidence regarding subjective facial self-
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assessment after MMA, which indicates that most patients perceive the facial change that
occurs as positive.53,54,86 The patient mentioned above who cited persistent numbness and
jaw pain also reported that her facial appearance became much worse after surgery, and
cited negative changes in her nose as her main complaint. She indicated in the survey
comments that she is considering plastic surgery to fix it, but is apprehensive about
undergoing another surgical procedure after her unpleasant experience with MMA.
The responses from Questions 33 reveal that nine (40.9%) of respondents felt that
the surgery made them look more youthful, while two (9.1%) thought it made them
appear older. No significant associations with age or sex were noted. It has been
documented that MMA has a “reverse face lift” effect, as advancing the facial skeleton
improves soft tissue support resulting in a rejuvenation of the face.87 It may also be
possible that these patients are more rested due to improvement of their OSA symptoms.
14 (63.6%) felt the surgery made them more attractive, which is consistent with data from
the previous question. With the data from our sample suggesting that the facial changes
resulting from the surgery are positive in most patients, and that the patients mostly
perceive the changes as making them appear more attractive and youthful, it appears that
MMA surgery may have an additional benefit of improving facial aesthetics in addition
to treating the OSA symptoms.
Several statistically significant associations between sex and variables that relate
to facial aesthetics were noted. Females felt significantly more attractive than did males
after the surgery (p=0.043), and females preferred their profiles more (p=.049). As
mentioned above, the current literature that examines esthetics in MMA patients have had
relatively few females in their samples, so finding associations between sex and MMA
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variable outcomes has been difficult.51,54,55,86 The respondents to the current survey were
50% male (n=11) and 50% female (n=11), which is a more evenly distributed
demographic than is presented in the current literature. However, due to the small
population size in our study (n=22), it is difficult to make confident associations between
sex and the outcome variables examined. Future studies should focus on larger sample
sizes with a more even gender distribution.
While it has been reported that the facial changes following MMA for the
treatment of OSA are perceived as positive by the patients despite sometimes extreme
jaw protrusion,54 societal bias often causes us to perceive mandibular protrusion as
masculine, while the typical feminine profile has more convexity and slight mandibular
retrognathia. Question 35 was derived from the Derriford Appearance Scale,70 and was
included to determine if the facial changes following MMA are perceived by patients as
masculine or feminine. Most respondents reported a neutral response to the question,
indicating they observed no difference with respect to masculinity/femininity (n=15,
68.2%). Interestingly, the one respondent who felt more feminine after the surgery was
female, and the four who felt more masculine were male. This is interpreted as a positive
finding, as while the majority of patients perceived no change with respect to
masculinity/femininity, those that did perceived the changes as being appropriate for their
respective genders. This is a novel topic in orthognathic surgery, and further studies may
be warranted to assess the effect that MMA has on perceived masculinity/femininity of
the face, both subjectively and objectively.
The patients who had orthodontic treatment as part of their treatment plan (n=17,
77.3%) were significantly more likely to report higher satisfaction with esthetic and
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social outcomes as a result of their treatment, in comparison to those who did not receive
orthodontic treatment (n=5, 22.7%). The reasons for not having orthodontics are variable,
from high cost to social stigma. It appears as though orthodontic treatment has a positive
effect on the self-image in the patients in our sample. It has been demonstrated that in
general, patients who undergo orthodontics in conjunction with conventional
orthognathic surgery are satisfied with treatment71,88,89. It may reasonable to recommend
orthodontic therapy for all eligible patients considering MMA surgery to improve the
subjective aesthetic outcome, as well as the overall perceived success of the treatment.
Patients with skeletal discrepancies in addition to OSA would benefit from orthodontics
to decompensate the dentition to allow for maximum surgical movements. A mandibular
retrognathic patient with a skeletal Class II malocclusion would benefit from upper
incisor proclination, as well as lower incisor uprighting to create the space needed to
sufficiently advance the mandible to correct the underlying skeletal discrepency. This is
less of a concern in patients with Class I skeletal patterns, where it may be desirable to
maintain the patient’s original maxillomandibular relationship.
The final series of questions were meant to assess the patients’ quality of life
overall, as well as to ascertain their overall satisfaction with the surgery. The data from
Question 36 indicate that 19 (86.4%) of respondents have a better quality of life now than
they did before surgery, and one respondent reported no change. No patients reported a
worse quality of life compared to the time before surgery. This is consistent with studies
by Lye et al50 and Goodday51 which suggest an improved quality of life in OSA patients
who undergo MMA. Although the patients were not asked directly about QoL in those
studies, the authors from their data infer it.
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Quality of life improvements have been reported with a number of other
interventions for OSA, including CPAP,90 UPPP,91 and oral appliances.92 It was not
possible to compare the results of these studies (or others) to ours for several reasons.
First, the measures to assess quality of life in these various studies are not the same ones
used to construct the questionnaire used in this study, so comparisons between them
would not be valid. Second, the questionnaire used in this study is specifically tailored
towards MMA patients, so a large number of questions regarding the experience of
surgical treatment would not apply to other treatment modalities. In particular, the
questions regarding facial aesthetics used in this study would not be applicable to the
other treatments as they do not have a large effect on facial aesthetics. To make valid
comparisons between QoL outcomes for different treatment modalities would require the
use of a questionnaire that is broad enough to be applicable to all potential treatments for
OSA.
Eighteen (81.8%) of respondents felt like the surgery was worthwhile, while none
indicated that they did not. This is similar to the findings of Goodday51 which found that
89% of patients in their sample were satisfied overall with their treatment. Sixteen
(72.7%) respondents claimed that they would go through the procedure again if they had
to, while two (9.1%) said that they would not. Of the two that said they wouldn’t, one
cited poor facial appearance and invasiveness of the procedures as her primary reasons,
while the other cited persistent jaw numbness and discomfort while eating. The same two
respondents reported that they would not recommend the procedure to family and friends
who may benefit from it, citing similar reasons, while the majority (n=17, 77.3%)
indicated that they would recommend the procedure to others.
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The study of MMA outcomes in OSA patients is a relatively novel area of
research, and there is a need for more study in this area. Studies with larger sample sizes
that potentially draw from multiple centers would be useful in producing more confident
conclusions, as well as potentially uncovering more associations between the question
outcomes and patient variables like sex and age. Although the questionnaire introduced
here could be used in further studies, it is a cross-sectional survey in the sense that the
participants were asked to compare their experiences now with their experiences before
surgery. Ideally, such a questionnaire would be distributed in a prospective manner
before and after MMA surgery so that the change can be analyzed. The questions in the
survey were worded so that the respondents were asked to compare how they feel
currently with a prior state of health, i.e. before surgery. These types of questions are
called “transition” questions, and are a common format in many health-related quality of
life measures like the OQLQ93, however they do pose some difficulties when they are
used. For example, it may be difficult for patients to recall their previous state of health
accurately if significant time has passed since the intervention, and how the patients
currently feel introduces bias in the responses. If patients are currently feeling well, they
are likely to report that they have improved, and if they are feeling ill or poor, they tend
to report that they have worsened94. Future versions of the questionnaire used in this
study should be able to be applied before and after the intervention so that the two time
points can be compared to each other.
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Conclusions
This study had the aim of assessing subjective patient outcomes related to general
quality of life, snoring, daytime sleepiness and functional sleep outcomes, functional
surgical outcomes, and facial aesthetics in a group of patients who underwent MMA
surgery for the treatment of OSA. A patient outcomes questionnaire was developed to
meet this objective. The following conclusions were derived:
1. MMA surgery for the treatment of OSA appears to have an overall positive effect
on patient quality of life.
2. MMA surgery appears to lead to subjective improvement of various sleep
outcomes including snoring, daytime sleepiness, and functional outcomes of
sleep. Most patients were able to discontinue CPAP after MMA surgery.
3. The subjective facial outcomes of MMA surgery appear to be overwhelmingly
neutral or positive, with patients feeling overall more youthful and attractive after
surgery. Females felt significantly more positive about their post-surgery facial
appearance than males.
4. Orthodontic treatment in conjunction with MMA appears to have a positive effect
on subjective post-treatment facial outcomes.
5. The experience of orthognathic surgery appears to be well tolerated in these
patients. Most would go through it again if they had to, and would recommend it
to others suffering from OSA.
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Suggestions for Future Research
1. The methodology in this study may be repeated in the future with a larger sample
size to increase study power and decrease risk of type II error. More participants
would reduce false negative findings and potentially uncover more associations
between patient variables (age, sex, AHI success, orthodontic treatment) and
outcome variables. Using data from multiple centres may be considered.
2. Future version of the questionnaire may be modified so that they can be
administered before and after treatment. This would eliminate the use of transition
questions, which may be unreliable in determining a past state of being.
3. Studies examining the perception of facial changes following MMA for the
treatment of OSA, including the perceived changes (if any) in the
masculinity/femininity of the changes.
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Appendix II
Quality of Life After Maxillomandibular Advancement Surgery for the
Treatment of Obstructive Sleep Apnea
Letter of Information/Consent

Principle Investigator
Dr. Ali Tassi Assistant Professor, Division of Graduate Orthodontics Schulich School
of Medicine and Dentistry The University of Western Ontario University Hospital –
Department of Dentistry
Co-Investigators
Dr. Michael Shimizu Assistant Professor, Division of Oral and Maxillofacial Surgery
Schulich School of Medicine and Dentistry The University of Western
Ontario University Hospital – Department of Dentistry
Dr. Andrew Emanuele Orthodontic Resident, Division of Graduate Orthodontics
Schulich School of Medicine and Dentistry University of Western Ontario
Introduction
You are being invited to participate in a research study directed by Dr. Michael
Shimizu and Dr. Ali Tassi along with their resident Dr. Andrew Emanuele, to
evaluate outcomes related to sleep and overall quality of life for patients who have
undergone maxillomandibular advancement surgery for treatment of obstructive
sleep apnea syndrome (OSAS). As you have undergone this treatment with Dr.
Michael Shimizu for treatment of sleep apnea, you qualify to participate in this
study, if you wish. We have provided this consent form for you to read carefully, and
will answer any questions you may have regarding the information it contains.
Purpose of Study
The purpose of the study is to assess patient outcomes with respect to sleep,
aesthetics, and quality of life after maxillomandibular advancement (MMA) surgery
for the treatment of obstructive sleep apnea. This information may help clinicians in
their case selection when considering MMA treatment. Dr. Andrew Emanuele, a
resident in the Graduate Orthodontics Program at the University of Western
Ontario, will administer the study. The study will consist of a questionnaire to be
filled out online.
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Procedures
The patients who will be invited to complete the survey are patients of Dr. Michael
Shimizu (UWO) who have undergone maxillomandibular advancement surgery for
treatment of obstructive sleep apnea. Participation in the study is completely
voluntary, and participants are able to withdraw their participation at any time. This
letter of information and consent describes the study so you can make an informed
decision on participating. Please take the time to make a decision and if necessary,
discuss this proposal with your family and friends as you feel inclined. Please feel
free to ask questions if anything is unclear or if there are phrases or words you do
not understand. You have been asked to participate because you have undergone
maxillomandibular advancement jaw surgery for treatment of obstructive sleep
apnea. If you agree to participate, you will be asked to click on a link to fill out a
questionnaire online. We will address any questions you may have as needed.
Number of Participants
There are 60 potential patients who may participate in this study.
Participant Inclusion and Exclusion Criteria
Participants will be included if they have undergone maxillomandibular
advancement for treatment of obstructive sleep apnea by Dr. Michael Shimizu, an
oral and maxillofacial surgeon on faculty at Western University’s Schulich School of
Medicine and Dentistry. Participants who are unable to give informed consent will
be excluded.
Description of the Research
As a participant in the study, you will be asked to fill out an online questionnaire.
This will take approximately 10-15 minutes and will consist of questions related to
your history of sleep apnea, the jaw advancement surgery you underwent for this
problem, as well as your satisfaction with this treatment and its effect on your
overall quality of life. Dr. Emanuele will examine and analyze the data collected to
draw conclusions regarding patient outcomes following maxillomandibular
advancement surgery for the treatment of obstructive sleep apnea. The only
information that will be used from your past medical records are the outcomes of
your past polysomnographic sleep studies. After completing the survey, no follow
up is required with respect to this research project specifically. This research
project will not interfere with normal scheduled follow-ups with Dr. Shimizu.
Time Requirements
The completion of the questionnaire should take approximately 10-15 minutes.
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Risks
It is possible that unpleasant memories of the period of time surrounding your
surgery may be revisited while completing the survey online.
Benefits
Participants in the study will be given an opportunity to express their opinions and
concerns pertaining to the results of their maxillomandibular advancement surgery
for treatment of obstructive sleep apnea.
Right to Refuse
Your participation in this study is voluntary. You may refuse to participate, refuse to
answer any questions or you may withdraw from the study at any time with no
effect on the results of your treatment. You do not waive any of your legal rights by
signing the consent form.
Compensation for Participation
There is no compensation for the study.
Use of Data
Data collected via the questionnaire will be secured via encrypted, and password
protected software and hard drives, and locked in appropriate University servers
and storage facilities.
New Findings
If, during the course of this study, new information becomes available that may
relate to your willingness to continue to participate, this information will be
provided to you by the investigator.
Confidentiality
Your privacy will be respected. If the results of this study are published, your name
will not be used and no information that discloses your identity will be collected or
released.
To monitor the conduct of research, the research team, authorized study personnel,
Western University Health Science Research Ethics Board and the Lawson Health
Research Institute may require access to your study-related records. Additionally,
representatives of the Research Ethics Board may follow up with you directly for the
same purpose.
All participants will be given a study number. Only that number will be used on any
study analysis related documents.
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By signing the consent form you allow Dr. Emanuele to review the questionnaire
you will fill in.
Contacts
If you have any questions during the study, or wish to withdraw from the study at
any time, you may contact Dr. Michael Shimizu, Dr. Ali Tassi at or Dr. Andrew
Emanuele. If you have any questions or concerns about your rights as a research
participant or the conduct of this study you may contact Dr. David Hill, Scientific
director, Lawson Health Research.
Consent
I have read and understand the consent form for this study. I have been given
sufficient time to consider the above information and to seek advice if so desired. I
have had the opportunity to ask questions which have been answered to my
satisfaction. I am voluntarily agreeing to participate in this study. I will print a copy
of this consent form for my own information, if I wish.
By signing below, I am agreeing to participate in this survey.
Signature: ________________________________________________________________________
Date: ________________________________________
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Appendix III
Jaw Surgery for Obstructive Sleep Apnea Outcomes Questionnaire

Please read each question carefully and checkmark what you feel is the most correct
answer:
Q1 In general, would you say your health is:







Excellent
Very Good
Good
Fair
Poor
I don't know

Q2 Compared to the time before your jaw surgery, how would you rate your health
in general now?







Much better than before
Somewhat better than before
About the same
Somewhat worse than before
Much worse than before
I don't know

Q3 Have you been diagnosed with any new medical conditions since having jaw
surgery? If yes, what condition(s) have you been diagnosed with?
 Yes ___________________________________________
 No
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Q4 Since having orthognathic surgery, do you feel like your sleep apnea has gotten
better or worse?







Much better
A little better
No change
A little worse
Much worse
I don't know

Q5 On average, how often are you still using a CPAP machine at night?






Every night or almost every night
3-4 times a week
1-2 times a week
1-2 times a month
Never or nearly never
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Q6 How likely are you to doze off or fall asleep in the following situations, in contrast to feeling just
tired? This refers to your usual way of life in recent times. Even if you have not done some of these
things recently try to work out how they would have affected you. Use the following scale to choose
the most appropriate number for each situation:
0 = no chance of dozing
1 = slight chance of dozing
2 = moderate chance of dozing
3 = high chance of dozing

0

1

2

3

Sitting and reading









Watching TV

























































Sitting inactive in a public
place (e.g. a theatre or
meeting)
As a passenger in a car for an
hour without a break
Lying down to rest in the
afternoon when
circumstances permit
Sitting and talking to
someone
Sitting quietly after a lunch
without alcohol
In a car, while stopped for a
few minutes in traffic
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Q7 What is your current weight (in pounds)?

Q8 What is your height (in feet/inches)?

Q9 According to what others have told you, do you currently snore?







Yes, nearly every night
Yes, 3-4 nights a week
Yes, 1-2 nights a week
Yes, 1-2 nights a month
Never or nearly never
I don't know

Q10 If you still snore, how loud have others said your snoring is?







Slightly louder than breathing
As loud as talking
Louder than talking
Very loud - can be heard in adjacent rooms
I do not snore
I don't know

Q11 How often, if ever, has anyone noticed that you quit breathing during your
sleep?







Never or nearly never
1-2 times a month
1-2 times a week
3-4 times a week
Nearly every night
I don't know
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Q12 Since having your surgery, do you snore more, or less than before?







Much more
A little more
About the same
A little less
Much less
I don't know

Q13 How loud is your snoring now, compared to before surgery?







Much louder
A little louder
About the same
A little quieter
Much quieter
I don't know

Q14 Since having your surgery, does your snoring bother other people more, or
less?







Much more
A little more
About the same
A little less
Much less
I don't know

Q15 Compared to the time before your surgery, do you feel more, or less refreshed
after your sleep (i.e. when you wake up in the morning)?







Much more refreshed
A little more refreshed
About the same
A little less refreshed
Much less refreshed
I don't know
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Q16 Compared to the time before your surgery, do you feel more, or less tired or
sleepy during the daytime?







Much more tired
A little more tired
About the same
A little less tired
Much less tired
I don't know

Q17 In comparison to before surgery, has the quality of your sleep become better or
worse?







Much better quality
A little better quality
About the same
A little worse quality
Much worse quality
I don't know

Q18 Since having surgery, have you had more, or less difficulty socializing with your
family and friends because you become sleepy or tired?







Much more difficulty
A little more difficulty
No difference
A little less difficulty
Much less difficulty
I don't know

Q19 Since having your surgery, do you have more, or less difficulty concentrating or
remembering things because you are sleepy or tired?







Much more difficulty
A little more difficulty
No difference
A little less difficulty
Much less difficulty
I don't know
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Q20 Compared to the time before your surgery, do you have more, or less difficulty
doing housework, exercising, or other forms of physical activity because you are
sleepy or tired?







Much more difficulty
A little more difficulty
No difference
A little less difficulty
Much less difficulty
I don't know

Q21 Compared to the time before your surgery, do you have more, or less difficulty
watching television, or sitting through a movie or lecture because you are sleepy or
tired?







Much more difficulty
A little more difficulty
No difference
A little less difficulty
Much less difficulty
I don't know

Q22 Since having surgery, has your mood been more, or less affected because you
are sleepy or tired?







Much more affected
A little more affected
No change
A little less affected
Much less affected
I don't know
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Q23 Since having surgery, do you have more, or fewer problems with biting or
chewing?







Much more problems
Slightly more problems
No difference
Slightly fewer problems
Much fewer problems
I don't know

Q24 Compared to the time before your surgery, do you experience more, or less pain
in your face, jaws, or jaw joints?







Much more pain
A little more pain
No difference
A little less pain
Much less pain
I don't know

Q25 Compared to the time immediately after surgery, to what extent has your facial
numbness improved?







Completely improved and back to normal
Improved a lot, almost back to normal
Improved a little, still some numbness
Barely improved at all, still very numb
No improvement, numbness is the same as the time immediately after surgery
I don't know
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Q26 Since having your surgery, do you have more, or less confidence when you are
out socially?







Much more confidence
A little more confidence
No difference
A little less confidence
Much less confidence
I don't know

Q27 Since having your surgery, are you more, or less self-conscious about your
facial appearance?







Much more self-conscious
A little more self-conscious
No difference
A little less self-conscious
Much less self-conscious
I don't know

Q28 Since having your surgery, are you more, or less self-conscious about the
appearance of your teeth and smile?







Much more self-conscious
A little more self-conscious
No difference
A little less self-conscious
Much less self-conscious
I don't know
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Q29 Since having jaw surgery, do you spend more, or less time studying your face in
the mirror?







Much more time
A little more time
No difference
A little less time
Much less time
I don't know

Q30 Since having surgery, how do you like the appearance of you face from the
front?







Much more than before
A little more than before
About the same
A little less than before
Much less than before
I don't know

Q31 Since having surgery, how do you like the appearance of your face from the side
(profile)?







Much more than before
A little more than before
About the same
A little less than before
Much less than before
I don't know
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Q32 Do you feel that your family and friends like your facial appearance more, or
less since having surgery?







Much more than before
A little more than before
About the same
A little less than before
Much less than before
I don't know

Q33 Do you feel like having orthognathic surgery has made you look younger or
older?







Much older
A little older
About the same
A little younger
Much younger
I don't know

Q34 Do you feel like having orthognathic surgery has made you more, or less
attractive?







Much more attractive
A little more attractive
About the same
A little less attractive
Much less attractive
I don't know
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Q35 Do you feel like having orthognathic surgery has made you look more
masculine or feminine?







Much more masculine
A little more masculine
No difference
A little more feminine
Much more feminine
I don't know

Q36 Have the results of your operation made your overall quality of life better, or
worse?







Much better
A little better
No change
A little worse
Much worse
I don't know

Q37 Overall do you feel like your experience with orthognathic surgery for the
treatment of your sleep apnea was worthwhile?
 Yes
 No
 I don't know

If not, why?
Q38 If you had to, would you go through the procedure again?
 Yes
 No
 I don't know

If not, why?
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Q39 Would you recommend orthognathic surgery to family and friends who are
suffering from sleep apnea?
 Yes
 No
 I don't know

If not, why?
Q40 If you wish, feel free to provide additional feedback about your experiences and
outcomes with respect to jaw surgery for the treatment of obstructive sleep apnea.

82

Appendix IV
Data from the collected questionnaires, presented according to question number.

Frequency

Percent

fair

1

4.5

Good

5

22.7

14

63.6

2

9.1

22

100.0

Very Good
Excellent
Total
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Frequency
Somewhat worse than

Percent

1

4.5

2

9.1

7

31.8

Much better than before

12

54.5

Total

22

100.0

before
About the same
Somewhat better than
before
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Frequency
Yes

Percent
4

18.2

No

18

81.8

Total

22

100.0
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Frequency

Percent

No change

1

4.5

A little better

2

9.1

Much better

19

86.4

Total

22

100.0
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Frequency
Every night or almost every

Percent

1

4.5

Never or nearly never

21

95.5

Total

22

100.0

night
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Questions 7 and 8

N
Q7: What is your current
weight (in pounds)?
Q8: What is your height (in
cm)?
N

Minimum

Maximum

Mean

Std. Deviation

22

125.00

379.0

195.0

55.9

22

160.00

193.4

174.4

9.3

22
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Frequency
Valid

Total

Percent

Yes, nearly every night

6

27.3

Yes, 3-4 nights a week

1

4.5

Yes, 1-2 nights a week

1

4.5

Yes, 1-2 nights a month

2

9.1

Never or nearly never

9

40.9

“I don’t know”

2

9.1

No response

1

4.5

22

100.0
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Frequency
Valid

Very loud - can be heard in

1

4.5

Louder than talking

3

13.6

As loud as talking

3

13.6

4

18.2

I do not snore

6

27.3

“I don’t know”

4

18.2

No response

1

4.5

22

100.0

adjacent rooms

Slightly louder than
breathing

Total

Percent
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Frequency
Valid

Nearly every night

1

4.5

3-4 times a week

1

4.5

1-2 times a month

1

4.5

11

50.0

“I don’t know”

7

31.8

No response

1

4.5

22

100.0

Never or nearly never

Total

Percent
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Frequency
Valid

Total

Percent

About the same

2

9.1

A little less

1

4.5

Much less

14

63.6

“I don’t know”

4

18.2

No response

1

4.5

22

100.0
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Frequency
Valid

Total

Percent

Much louder

1

4.5

About the same

2

9.1

A little quieter

1

4.5

Much quieter

10

45.5

“I don’t know”

7

31.8

No response

1

4.5

22

100.0
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Frequency
Valid

Total

Percent

About the same

1

4.5

A little less

2

9.1

Much less

14

63.6

“I don’t know”

4

18.2

No response

1

4.5

22

100.0

94

Frequency
Valid

About the same

2

9.1

A little more refreshed

5

22.7

Much more refreshed

14

63.6

1

4.5

22

100.0

No response
Total

Percent

95

Frequency
Valid

About the same

2

9.1

A little less tired

5

22.7

Much less tired

14

63.6

1

4.5

22

100.0

No response
Total

Percent

96

Frequency
Valid

About the same

1

4.5

A little better quality

7

31.8

Much better quality

13

59.1

1

4.5

22

100.0

No response
Total

Percent

97

Frequency
Valid

Total

Percent

No difference

5

22.7

A little less difficulty

6

27.3

Much less difficulty

9

40.9

No response

2

9.1

22

100.0

98

Frequency
Valid

Total

Percent

A little more difficulty

1

4.5

No difference

2

9.1

A little less difficulty

10

45.5

Much less difficulty

7

31.8

No response

2

9.1

22

100.0

99

Frequency
Valid

A little more difficulty

1

4.5

No difference

1

4.5

A little less difficulty

7

31.8

Much less difficulty

12

54.5

1

4.5

22

100.0

No response
Total

Percent

100

Frequency
Valid

No difference

2

9.1

A little less difficulty

7

31.8

Much less difficulty

12

54.5

1

4.5

22

100.0

No response
Total

Percent

101

Frequency
Valid

A little more affected

2

9.1

No change

3

13.6

A little less affected

6

27.3

Much less affected

10

45.5

1

4.5

22

100.0

No response
Total

Percent

102

Frequency
Valid

Total

Percent

Much more problems

1

4.5

Slightly more problems

4

18.2

No difference

5

22.7

Slightly fewer problems

4

18.2

Much fewer problems

7

31.8

No response

1

4.5

22

100.0

103

Frequency
Valid

Total

Percent

Much more pain

2

9.1

A little more pain

5

22.7

No difference

6

27.3

A little less pain

2

9.1

Much less pain

5

22.7

“I don’t know”

1

4.5

No response

1

4.5

22

100.0

104

Frequency
Valid

Barely improved at all, still
very numb
Improved a little, still some
numbness
Improved a lot, almost back
to normal
Completely improved and
back to normal
No response

Total

Percent

3

13.6

5

22.7

8

36.4

5

22.7

1

4.5

22

100.0

105

Frequency
Valid

Much less confidence

1

4.5

A little less confidence

1

4.5

10

45.5

A little more confidence

5

22.7

Much more confidence

4

18.2

No response

1

4.5

22

100.0

No difference

Total

Percent

106

Frequency
Valid

Total

Percent

Much more self-conscious

3

13.6

A little more self-conscious

1

4.5

No difference

6

27.3

A little less self-conscious

5

22.7

Much less self-conscious

6

27.3

No response

1

4.5

22

100.0

107

Frequency
Valid

Total

Percent

Much more self-conscious

2

9.1

A little more self-conscious

1

4.5

No difference

7

31.8

A little less self-conscious

4

18.2

Much less self-conscious

7

31.8

No response

1

4.5

22

100.0

108

Frequency
Valid

Much more time

1

4.5

A little more time

5

22.7

13

59.1

Much less time

2

9.1

No response

1

4.5

22

100.0

No difference

Total

Percent

109

Frequency
Valid

Total

Percent

Much less than before

1

4.5

About the same

6

27.3

A little more than before

9

40.9

Much more than before

5

22.7

No response

1

4.5

22

100.0

110

Frequency
Valid

Total

Percent

Much less than before

1

4.5

About the same

6

27.3

A little more than before

4

18.2

Much more than before

7

31.8

“I don’t know”

3

13.6

No response

1

4.5

22

100.0

111

Frequency
Valid

Total

Percent

Much less than before

1

4.5

About the same

6

27.3

A little more than before

4

18.2

Much more than before

7

31.8

“I don’t know”

3

13.6

No response

1

4.5

22

100.0

112

Frequency
Valid

Total

A little older

Percent

2

9.1

About the same

10

45.5

A little younger

7

31.8

Much younger

2

9.1

No response

1

4.5

22

100.0

113

Frequency
Valid

Total

Percent

Much less attractive

1

4.5

A little less attractive

1

4.5

About the same

4

18.2

A little more attractive

10

45.5

Much more attractive

4

18.2

I don’t know”

1

4.5

No response

1

4.5

22

100.0

114

Frequency
Valid

Much more masculine

1

4.5

A little more masculine

3

13.6

15

68.2

A little more feminine

1

4.5

“I don’t know”

1

4.5

No response

1

4.5

22

100.0

No difference

Total

Percent

115

Frequency
Valid

Total

Percent

No change

1

4.5

A little better

7

31.8

Much better

12

54.5

No response

2

9.1

22

100.0

116

Frequency
Valid

Yes
“I don’t know”

No response
Total

Percent
18

81.8

1

4.5

3

13.6

22

100.0

117

Frequency
Valid

Total

Percent

Yes

16

72.7

No

2

9.1

“I don’t know”

2

9.1

No response

2

9.1

22

100.0

118

Frequency
Valid

Percent

Yes

17

77.3

No

2

9.1

3

13.6

22

100.0

No response

Total

119
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